Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial
Mullen, M., Jin, X.Y., Child, A., Stuart, A.G., Dodd, M., Aragon-Martin, J.A., Gaze, D.C., Kiotsekoglou, A., Yuan, L., Hu, J., Foley, C., Van Dyck, L., Knight, R., Clayton, T., Swan, L., Thomson, J.D.R., Erdem, G., Crossman, D., Flather, M., Dean, J., Was, B., Gow, H., Murray, J., D'Allessandro, M., Christie, M., Cooper, P., Booth, P., Burns, S., Paterson, Y., Chikermane, A., Assing, A., Cotter, C., Atkins, G., Williamson, H., Barclay, J., Jennison, A., Henderson, A., McSkeane, A., Fairlamb, H., Kelly, J., Kelsall, N., Prentice, S., O'Sullivan, J., Head-Baister, A., Phillipson, A., Johnson, A., Crossland, D., Oliver, J., Davison, J., Wake, J., Quinn, L., Foreman, M., Wealleans, V., Walker, N., Duncan, A., Tibbs, E., Kelly, R., Khambadkone, S., Zotti, B., Brady, C., Cervi, E., Field, E., Szepezvary, E., Mantey, F., Riley, G., Titmus, H., Bo, I., Kaski, J.P., Green, L., Jones, N., Banks, R., Kiesewetter, C., Mathur, S., Frigiola, A., Savis, A., Belfield, H., Guzman, J., Harris, J., Wilson, K., Peacock, K., Gibson, K., Wellman, P., Simpson, J., Kabir, S., Mushemi, S., Stewart, M., Atkinson, B., Richardson, C., Leng, E., Brennan, P., Nixon, A., Spencer, C., Oliver, J., Forster, J., Turner, L., Bainbridge, S., Choy, A.M., Dawson, A., Kiddie, G., Kerr, H., Mordi, I., Duff, J., Dunlop, J., Berg, J., Armory, P., Freeman, L., Anwar, A., Graham, C., London, C., Healey, G., Gallagher, I., Ilsley, M., Ahmed, R., Wood, S., Wheeldon, N., Mason, C., Nassim, F., Middle, J., Adams, J., Angelini, K., Housley, K., Ryalls, K., Agyemang, M., Walker, R., Batigan, R., Bennett, T., Clift, P., Alvior, A.M., Nilsson, A., Green, C., Crook, C., Palmer, C.B., Dwenger, E., Doherty, P., Igbokwe, R., Sharif, S., MacDonald, S., West, C., Kirby, K., Naqvi, N., Welch, S., Warsama, S., Li, W., Farzad, Z., Smith, B., Murday, V., Murtagh, E., Adams, E., Armour, L., Lilley, S., Pandya, B., Richards, A., Andiapen, M., Macrae, R., Tome, M., Hutchinson, C., Angulo, K., Kauppayamootoo, R., Gati, S., Cruddas, E., Newman, W.G., Breen, C., Kumar, D., Wilson, D.G., Farrugia, A., Fraser, A., Sumers, J., Powell, J., Edwards, J., Hale, T., Boult, Z., Carroll, A., Veldtman, G., Ho, A., Black, D., Fletcher, L., Mapstone, S., Bharucha, T., Marsh, G., Jones, J., Sheehan, K., Selway, K., Stevenson, K., Nelson, M., Fairweather, R., Curtis, S., Simpson, S., Denvir, M., White, A., Steven, J., Munro, J., Lam, W., Toff, W., Petrou, M., Silcocks, P. and MacAllister, R. 2019. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. The Lancet. 394 (10216), pp. 2263-2270. https://doi.org/10.1016/s0140-6736(19)32518-8